Mainz Selling General Administrative from 2010 to 2025

MYNZ Stock  USD 4.83  0.18  3.87%   
Mainz Biomed Selling General Administrative yearly trend continues to be fairly stable with very little volatility. Selling General Administrative will likely drop to about 8.9 M in 2025. During the period from 2010 to 2025, Mainz Biomed Selling General Administrative regression line of annual values had r-squared of  0.57 and arithmetic mean of  4,266,697. View All Fundamentals
 
Selling General Administrative  
First Reported
2019-03-31
Previous Quarter
4.8 M
Current Value
3.5 M
Quarterly Volatility
2.2 M
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.2 M or Interest Expense of 977.6 K, as well as many indicators such as Price To Sales Ratio of 22.99, Dividend Yield of 0.0 or PTB Ratio of 5.48. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Mainz Biomed BV over the last few years. It is Mainz Biomed's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Mainz Selling General Administrative Regression Statistics

Arithmetic Mean4,266,697
Geometric Mean1,135,374
Coefficient Of Variation147.87
Mean Deviation5,337,228
Median388,785
Standard Deviation6,309,292
Sample Variance39.8T
Range17.5M
R-Value0.75
Mean Square Error18.4T
R-Squared0.57
Significance0.0007
Slope999,601
Total Sum of Squares597.1T

Mainz Selling General Administrative History

20258.9 M
202415.4 M
202313.4 M
202217.8 M
20218.5 M
2020348 K

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Selling General Administrative, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative15.4 M8.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.